购物车
全部删除
您的购物车当前为空
别名 α-葡萄糖苷酶-IN-23
α-Glucosidase-IN-23 是具有口服活性的 α-Glucosidase 抑制剂。α-Glucosidase-IN-23 通过抑制 a-glucosidase 降低血糖 (IC50= 4.48 μM)。α-Glucosidase-IN-23 可用于糖尿病的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
α-Glucosidase-IN-23 是具有口服活性的 α-Glucosidase 抑制剂。α-Glucosidase-IN-23 通过抑制 a-glucosidase 降低血糖 (IC50= 4.48 μM)。α-Glucosidase-IN-23 可用于糖尿病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 828 | 现货 | |
| 5 mg | ¥ 2,000 | 现货 | |
| 10 mg | ¥ 2,800 | 现货 | |
| 25 mg | ¥ 4,130 | 现货 | |
| 50 mg | ¥ 5,610 | 现货 | |
| 100 mg | ¥ 7,430 | 现货 | |
| 200 mg | ¥ 9,830 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,350 | 现货 |
α-Glucosidase-IN-23 相关产品
| 产品描述 | α-Glucosidase-IN-23 is an orally active α-Glucosidase inhibitor. α-Glucosidase-IN-23 can decrease blood glucose by α-glucosidase inhibition (IC50= 4.48 μM). |
| 体外活性 | α-Glucosidase-IN-23(1 μM)展现出显著的抗糖尿病活性,通过抑制α-葡萄糖苷酶(IC50= 4.48 μM)降低血糖,同时降低β细胞和肌肉细胞中的ROS水平[1]。 |
| 体内活性 | α-Glucosidase-IN-23(口服;0.2 mmol/kg/天)仅在小鼠中抑制α-Glucosidase[1]。 |
| 别名 | α-葡萄糖苷酶-IN-23 |
| 分子量 | 373.4 |
| 分子式 | C20H23NO6 |
| CAS No. | 161187-57-1 |
| Smiles | C(OCC)(=O)C=1C(C(C(OCC)=O)=C(C)NC1C)C2=C3C(=CC=C2)OCO3 |
| 密度 | 1.225 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (66.95 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容